SlideShare a Scribd company logo
A Day in the Life of a Medical Director
Dr Glenn Carter
Healthcare Professionals Group
Medical Director’s role
The role of a Medical Director is to oversee all activities
within a company's Medical Department and to contribute
to company-wide business operations through involvement
in the senior leadership team.
Medical Director’s activities
1. Emails
2. Phone Calls
3. Internal Meetings
4. External Meetings
5. Travel
Emails
Head Office questions requesting updates on clinical trials, regulatory or health economics
submissions eg
“How is patient recruitment going in x trial”?
“What did x investigator think about the draft protocol for the new trial”?
“How many patients will Australia be able to commit to the global clinical trial program for x compound?
“Here are the results from x trial to discuss with your investigators”
“Here are the responses to the questions the TGA are asking about the compound which is being reviewed for registration”
“Here is some additional data to include in the reimbursement submission”
“Here is a report on the serious adverse events in x trial”
Phone Calls
Calls will be received from trial investigators about Inclusion/ Exclusion criteria, or the clinical
protocol:
"My patient is also taking x drug can I enrol him";
"If the patient had missed 2 visits can they continue in the trial?”
Calls will also be coming in from CRAs who are on-site at hospitals doing monitoring visits
"The study nurse needs more drug and I need your help in getting head office to send it quickly"
Phone Calls
There will also be phone calls from:
 the press asking for a response to an overseas news piece
 patient associations regarding sponsorship
 doctors requesting patient-specific medical advice
 investigators asking to have their own trials supported
As the medical leader within companies the Medical Director is frequently asked to publicly
comment on a range of topics, and would have undergone media training.
Internal Meetings
In the Clinical Research meetings a whole range of issues will be discussed. Progress made in all
the clinical trials will be regularly reviewed. Topics of conversation will centre around:
 Ethics Committee approvals
 strategies to increase patient recruitment
 availability of trial materials
 site issues and management
 trial budgets and payments
 adverse event reporting
New trial protocols will also be discussed. This will involve reviewing protocols sent from Head
Office, discussing whether they are applicable to Australian medical practice and identifying
potential investigators.
Internal Meetings
In the Regulatory meetings the topics will include:
 registration of New Chemical Entities, new dosage forms and new indications
 updates on timelines for regulatory submissions
 discussion on bottlenecks and issues which may delay registration.
 correspondence from the TGA will be reviewed and appropriate responses drafted
 the wording of PIs and CMIs will be finalised
During the Medical Information meetings company promotional literature will be analysed to ensure
that it meets Code of Conduct guidelines, with approval being given by the Medical Director prior to
printing and distribution.
Internal Meetings
The focus during the Health Economics meetings is on reimbursement and market access:
 the strategy for PBAC submissions will be decided upon
 the clinical data supporting the pricing strategy will be analysed
 additional supporting trials or analyses will be considered
 input from consultants (eg on economic modelling) and direction from head office (eg on
international pricing) will be used to determine the negotiation strategy with the PBAC
 discussion on the design of future clinical trials to ensure that they collect the right information for
submissions
The Medical Director's input will also include suggesting disease relevant health status
questionnaires and Quality of Life instruments to incorporate into the trial design, as well as suitable
gold standard comparator treatments relevant to medical practice in Australia.
Internal Meetings
The Medical Director is also involved with across-company meetings.
The Medical Director's medical knowledge and understanding of how patients are treated is useful
when annual marketing plans are devised. Topics during these meetings include:
 sales forecasts
 market trends
 competitor activity
 promotional programs
 disease management programs
 patient characteristics
 prescriber behaviour
Internal Meetings
During senior management meetings (also attended by the Managing Director, Sales and Marketing
Director, Operations Director, Human Resources Director and Finance Director) the Medical Director
will contribute to across- business discussions where a wide range of topics will include:
 operational and strategic planning
 resource management
 learning and development plans
 succession planning
 manufacturing and supply chain issues
 policy development
 external and corporate affairs initiatives
 crisis management
 monitoring of the company's trading and cash flow position
External Meetings
The Medical Director may be responsible for assembling and managing Key Opinion Leader
advisory groups for key products. The advisory group's role is to:
 review particular products (pre-launch or marketed)
 discuss where the product fits into the management of the patient's disease
 to suggest synergies with other company products
 to discuss leading developments in the field
Information gained during these discussions is then summarized and made available to marketing
and R&D functions.
External Meetings
It is also likely that the Medical Director will participate in Medicines Australia and other industry
committees thus ensuring that their company has a high level of professional standing.
External meetings will also include co-visiting doctors with CRAs to discuss current and future
clinical trials, and with sales reps to discuss the company's marketed products.
Travel
Canberra to meet with the TGA to discuss scientific and clinical data with the regulators and build
on-going relationships with key people.
Overseas meetings with Medical Directors from other countries there will be discussions on global
clinical development programs; regulatory timelines for key compounds and strategies to gather
data in support of reimbursement and market access.
Regional offices (eg Singapore) or global Head Office (US, UK or Europe) for meetings with internal
colleagues to build relationships; to request resources and headcount for Australia and to provide
updates on clinical trials and regulatory, reimbursement and other medical issues
Summary
The typical day of a Medical Director within an Australian pharmaceutical company is varied and
complex.
As the company's senior medical person they are called upon to use their clinical knowledge and
understanding of patient treatment protocols to advise their internal colleagues on clinical research,
regulatory, medical information, reimbursement and sales and marketing issues.
As a member of the senior leadership team they use their medical knowledge and commercial
acumen to contribute to the overall success of the company.
Health & Aged Care Professionals
Recruiting all clinical care, management and operational positions with Public and Private Hospitals; Medical Practices;
Imaging Service Providers; Health Insurance Funds; and Aged Care providers, residential facilities and affiliated service
providers
www.hacpconnect.com
Pharmaceutical & Medical Professionals
Recruiting all positions, at all levels, into biotechnology, medical devices, pharmaceutical and scientific companies
www.pmpconnect.com
Rural & Remote Healthcare Professionals
Recruiting doctors, nurses, allied health professionals, and healthcare administrators into rural and remote hospitals and
medical practices
www.rrhpconnect.com

More Related Content

What's hot

Good clinical practices
Good clinical practicesGood clinical practices
Good clinical practices
Dhruva Sharma
 
Market Access
Market AccessMarket Access
Market Access
Gergana Nash
 
Parkville strategic project final-converted
Parkville   strategic project final-convertedParkville   strategic project final-converted
Parkville strategic project final-converted
Mohamed Ahmed
 
RWE and Digital Health whitepaper (email)
RWE and Digital Health whitepaper (email)RWE and Digital Health whitepaper (email)
RWE and Digital Health whitepaper (email)
Ulrich Neumann, FRSA
 
OTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADE
OTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADEOTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADE
OTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADE
THILAKAR MANI
 
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio MedixHow Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
ambitbiomedix12
 
Pharmaceutical Marketing Strategies
Pharmaceutical Marketing StrategiesPharmaceutical Marketing Strategies
Pharmaceutical Marketing Strategies
Muhammad Ali Jehangir
 
Introduction to Digital Health (EN)
Introduction to Digital Health (EN)Introduction to Digital Health (EN)
Introduction to Digital Health (EN)
Adriano Fontanari
 
Pharmaceutical Marketing
Pharmaceutical MarketingPharmaceutical Marketing
Pharmaceutical Marketing
Ravindran Kanningat
 
Customized Patient Care through Patient Support Programs for Rare/Orphan Drugs
Customized Patient Care through Patient Support Programs for Rare/Orphan DrugsCustomized Patient Care through Patient Support Programs for Rare/Orphan Drugs
Customized Patient Care through Patient Support Programs for Rare/Orphan Drugs
Canadian Organization for Rare Disorders
 
Global Promotional Review
Global Promotional Review Global Promotional Review
Global Promotional Review
Alan Bergstrom
 
The Over-The-Counter Drug Industry
The Over-The-Counter Drug IndustryThe Over-The-Counter Drug Industry
The Over-The-Counter Drug Industry
Piyush Tripathi
 
Merck - Strategic Plan.docx
Merck - Strategic Plan.docxMerck - Strategic Plan.docx
Merck - Strategic Plan.docx
JaswanthSeera
 
Pharmacy “it’s even more than you can imagine.”
Pharmacy “it’s even more than you can imagine.”Pharmacy “it’s even more than you can imagine.”
Pharmacy “it’s even more than you can imagine.”
Nani Karnam Vinayakam
 
WHODrug as linked data
WHODrug as linked dataWHODrug as linked data
WHODrug as linked data
Magnus Wallberg
 
Integrating Siebel CTMS with Medidata Rave and Veeva Vault
Integrating Siebel CTMS with Medidata Rave and Veeva VaultIntegrating Siebel CTMS with Medidata Rave and Veeva Vault
Integrating Siebel CTMS with Medidata Rave and Veeva Vault
Perficient, Inc.
 
Roles and responsibility of a CRC
Roles and responsibility of a CRCRoles and responsibility of a CRC
Roles and responsibility of a CRC
Jagriti Bansal
 
Patient centric strategy
Patient centric strategyPatient centric strategy
Patient centric strategy
Jean-Michel Peny
 
Schedule Y
Schedule YSchedule Y
Schedule Y
kamalakar ambati
 
RATIONAL USE OF DRUGS.ppt
RATIONAL USE OF DRUGS.pptRATIONAL USE OF DRUGS.ppt
RATIONAL USE OF DRUGS.ppt
BALASUNDARESAN M
 

What's hot (20)

Good clinical practices
Good clinical practicesGood clinical practices
Good clinical practices
 
Market Access
Market AccessMarket Access
Market Access
 
Parkville strategic project final-converted
Parkville   strategic project final-convertedParkville   strategic project final-converted
Parkville strategic project final-converted
 
RWE and Digital Health whitepaper (email)
RWE and Digital Health whitepaper (email)RWE and Digital Health whitepaper (email)
RWE and Digital Health whitepaper (email)
 
OTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADE
OTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADEOTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADE
OTC DRUG REVIEW, DRUG AMENDENT, COPY RIGHT, PATENT AND TRADE
 
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio MedixHow Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medix
 
Pharmaceutical Marketing Strategies
Pharmaceutical Marketing StrategiesPharmaceutical Marketing Strategies
Pharmaceutical Marketing Strategies
 
Introduction to Digital Health (EN)
Introduction to Digital Health (EN)Introduction to Digital Health (EN)
Introduction to Digital Health (EN)
 
Pharmaceutical Marketing
Pharmaceutical MarketingPharmaceutical Marketing
Pharmaceutical Marketing
 
Customized Patient Care through Patient Support Programs for Rare/Orphan Drugs
Customized Patient Care through Patient Support Programs for Rare/Orphan DrugsCustomized Patient Care through Patient Support Programs for Rare/Orphan Drugs
Customized Patient Care through Patient Support Programs for Rare/Orphan Drugs
 
Global Promotional Review
Global Promotional Review Global Promotional Review
Global Promotional Review
 
The Over-The-Counter Drug Industry
The Over-The-Counter Drug IndustryThe Over-The-Counter Drug Industry
The Over-The-Counter Drug Industry
 
Merck - Strategic Plan.docx
Merck - Strategic Plan.docxMerck - Strategic Plan.docx
Merck - Strategic Plan.docx
 
Pharmacy “it’s even more than you can imagine.”
Pharmacy “it’s even more than you can imagine.”Pharmacy “it’s even more than you can imagine.”
Pharmacy “it’s even more than you can imagine.”
 
WHODrug as linked data
WHODrug as linked dataWHODrug as linked data
WHODrug as linked data
 
Integrating Siebel CTMS with Medidata Rave and Veeva Vault
Integrating Siebel CTMS with Medidata Rave and Veeva VaultIntegrating Siebel CTMS with Medidata Rave and Veeva Vault
Integrating Siebel CTMS with Medidata Rave and Veeva Vault
 
Roles and responsibility of a CRC
Roles and responsibility of a CRCRoles and responsibility of a CRC
Roles and responsibility of a CRC
 
Patient centric strategy
Patient centric strategyPatient centric strategy
Patient centric strategy
 
Schedule Y
Schedule YSchedule Y
Schedule Y
 
RATIONAL USE OF DRUGS.ppt
RATIONAL USE OF DRUGS.pptRATIONAL USE OF DRUGS.ppt
RATIONAL USE OF DRUGS.ppt
 

Viewers also liked

Data Science in Drug Discovery
Data Science in Drug DiscoveryData Science in Drug Discovery
Data Science in Drug Discovery
WrangleConf
 
Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.
Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.
Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.
OpenVZ
 
Thermal Management And Sd0802 C Presentation
Thermal Management And Sd0802 C PresentationThermal Management And Sd0802 C Presentation
Thermal Management And Sd0802 C Presentation
sforman1
 
05 enclosures
05 enclosures05 enclosures
05 enclosures
psize web
 
Memuary Tetrad 1
Memuary Tetrad 1Memuary Tetrad 1
Memuary Tetrad 1
Denis Golikov
 
Pppp
PpppPppp
The engineer’s licensing guidance document ELGD 2007
The engineer’s licensing guidance document ELGD 2007The engineer’s licensing guidance document ELGD 2007
The engineer’s licensing guidance document ELGD 2007
International Society for Licensed Aircraft Maintenance Engineers
 
Ts 2992
Ts 2992Ts 2992
Ts 2992
Bin Shao
 
Li & fung ltd
Li & fung ltdLi & fung ltd
Li & fung ltd
Priyanka Chowdhury
 
Sxsf
SxsfSxsf
Sxsf
sajeerpm
 
Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases
Niuchangchih (Antrodia camphorata) and its potential in treating liver diseasesNiuchangchih (Antrodia camphorata) and its potential in treating liver diseases
Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases
Affiliate marketing
 
Newton's laws jeopardy
Newton's laws jeopardyNewton's laws jeopardy
Newton's laws jeopardy
rlinde
 
The Regacy Chapter 5.4b Ink - Emma
The Regacy Chapter 5.4b Ink - EmmaThe Regacy Chapter 5.4b Ink - Emma
The Regacy Chapter 5.4b Ink - Emma
regacylady
 
Bogovete na promqnata
Bogovete na promqnataBogovete na promqnata
Bogovete na promqnataqdessy
 
ニコニコ動画でのHTML5
ニコニコ動画でのHTML5ニコニコ動画でのHTML5
ニコニコ動画でのHTML5
Sho KUSANO
 
Futsalf
FutsalfFutsalf
Futsalf
parenti55
 
7 Deadly Sins of Tech
7 Deadly Sins of Tech7 Deadly Sins of Tech
7 Deadly Sins of Tech
Rob Dyke
 
Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...
Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...
Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...
Teemu Karvonen
 
Well known magazine name analysis
Well known magazine name analysisWell known magazine name analysis
Well known magazine name analysis
shaunWhelan
 

Viewers also liked (20)

Data Science in Drug Discovery
Data Science in Drug DiscoveryData Science in Drug Discovery
Data Science in Drug Discovery
 
Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.
Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.
Profit from the cloud TM Parallels Dynamic Infrastructure And OpenStack.
 
Thermal Management And Sd0802 C Presentation
Thermal Management And Sd0802 C PresentationThermal Management And Sd0802 C Presentation
Thermal Management And Sd0802 C Presentation
 
05 enclosures
05 enclosures05 enclosures
05 enclosures
 
Memuary Tetrad 1
Memuary Tetrad 1Memuary Tetrad 1
Memuary Tetrad 1
 
August 2012
August 2012August 2012
August 2012
 
Pppp
PpppPppp
Pppp
 
The engineer’s licensing guidance document ELGD 2007
The engineer’s licensing guidance document ELGD 2007The engineer’s licensing guidance document ELGD 2007
The engineer’s licensing guidance document ELGD 2007
 
Ts 2992
Ts 2992Ts 2992
Ts 2992
 
Li & fung ltd
Li & fung ltdLi & fung ltd
Li & fung ltd
 
Sxsf
SxsfSxsf
Sxsf
 
Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases
Niuchangchih (Antrodia camphorata) and its potential in treating liver diseasesNiuchangchih (Antrodia camphorata) and its potential in treating liver diseases
Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases
 
Newton's laws jeopardy
Newton's laws jeopardyNewton's laws jeopardy
Newton's laws jeopardy
 
The Regacy Chapter 5.4b Ink - Emma
The Regacy Chapter 5.4b Ink - EmmaThe Regacy Chapter 5.4b Ink - Emma
The Regacy Chapter 5.4b Ink - Emma
 
Bogovete na promqnata
Bogovete na promqnataBogovete na promqnata
Bogovete na promqnata
 
ニコニコ動画でのHTML5
ニコニコ動画でのHTML5ニコニコ動画でのHTML5
ニコニコ動画でのHTML5
 
Futsalf
FutsalfFutsalf
Futsalf
 
7 Deadly Sins of Tech
7 Deadly Sins of Tech7 Deadly Sins of Tech
7 Deadly Sins of Tech
 
Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...
Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...
Adapting the Lean Enterprise Self-Assessment Tool for Software Development Do...
 
Well known magazine name analysis
Well known magazine name analysisWell known magazine name analysis
Well known magazine name analysis
 

Similar to A Day in the Life of a Medical Director

Regulatory Affairs
Regulatory AffairsRegulatory Affairs
Regulatory Affairs
ShabeenaZaidi
 
Medical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report SummaryMedical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report Summary
Best Practices, LLC
 
Accelerating Bio-Pharma's Marketing Transformation
Accelerating Bio-Pharma's Marketing TransformationAccelerating Bio-Pharma's Marketing Transformation
Accelerating Bio-Pharma's Marketing Transformation
Cognizant
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organization
Dr. Zubair Ali
 
Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009
Cameron Tew
 
JournalofPrecisionMedicine_May_June2016
JournalofPrecisionMedicine_May_June2016JournalofPrecisionMedicine_May_June2016
JournalofPrecisionMedicine_May_June2016
Franziska Moeckel, MBA
 
Helping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker ProgramsHelping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker Programs
Cognizant
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science Liasons
Jean-Michel Peny
 
Do you know how many rewarding job opportunities exist in the Clinical resea...
Do you know how many rewarding  job opportunities exist in the Clinical resea...Do you know how many rewarding  job opportunities exist in the Clinical resea...
Do you know how many rewarding job opportunities exist in the Clinical resea...
Access-Pharma Jobs
 
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
Nathan White, CPC
 
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Best Practices, LLC
 
6 proven-ways-to-supplement-your-clinical-income
6 proven-ways-to-supplement-your-clinical-income6 proven-ways-to-supplement-your-clinical-income
6 proven-ways-to-supplement-your-clinical-income
Afaq Ali
 
Entry into the pharmaceutical and medical industry
Entry into the pharmaceutical and medical industryEntry into the pharmaceutical and medical industry
Entry into the pharmaceutical and medical industry
Pharmaceutical & Medical Professionals
 
A shock to the system
A shock to the systemA shock to the system
A shock to the system
Mahamid Rahman
 
Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
Deepak Raj (2,000+Connections)
 
6th annual clinical trials summit 2015
6th annual clinical trials summit 20156th annual clinical trials summit 2015
6th annual clinical trials summit 2015
Deepak Raj (2,000+Connections)
 
Presentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchPresentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and research
klaffy
 
Dina-CV
Dina-CVDina-CV
Dina-CV
Dina Eldaour
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
Dipak Bhingardeve
 
Pharmacy Orientation.pdf
Pharmacy Orientation.pdfPharmacy Orientation.pdf
Pharmacy Orientation.pdf
HarisSaeedM03
 

Similar to A Day in the Life of a Medical Director (20)

Regulatory Affairs
Regulatory AffairsRegulatory Affairs
Regulatory Affairs
 
Medical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report SummaryMedical Affairs Resources, Structures, & Trends Report Summary
Medical Affairs Resources, Structures, & Trends Report Summary
 
Accelerating Bio-Pharma's Marketing Transformation
Accelerating Bio-Pharma's Marketing TransformationAccelerating Bio-Pharma's Marketing Transformation
Accelerating Bio-Pharma's Marketing Transformation
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organization
 
Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009
 
JournalofPrecisionMedicine_May_June2016
JournalofPrecisionMedicine_May_June2016JournalofPrecisionMedicine_May_June2016
JournalofPrecisionMedicine_May_June2016
 
Helping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker ProgramsHelping Pharmas Manage Compliance Risks for Speaker Programs
Helping Pharmas Manage Compliance Risks for Speaker Programs
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science Liasons
 
Do you know how many rewarding job opportunities exist in the Clinical resea...
Do you know how many rewarding  job opportunities exist in the Clinical resea...Do you know how many rewarding  job opportunities exist in the Clinical resea...
Do you know how many rewarding job opportunities exist in the Clinical resea...
 
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
What’s Next in US Payor Communications: The Impact of FDA's Proposed Guidance...
 
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...Educating KOLs, Physicians, Patients, and Payers to support successful produc...
Educating KOLs, Physicians, Patients, and Payers to support successful produc...
 
6 proven-ways-to-supplement-your-clinical-income
6 proven-ways-to-supplement-your-clinical-income6 proven-ways-to-supplement-your-clinical-income
6 proven-ways-to-supplement-your-clinical-income
 
Entry into the pharmaceutical and medical industry
Entry into the pharmaceutical and medical industryEntry into the pharmaceutical and medical industry
Entry into the pharmaceutical and medical industry
 
A shock to the system
A shock to the systemA shock to the system
A shock to the system
 
Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
 
6th annual clinical trials summit 2015
6th annual clinical trials summit 20156th annual clinical trials summit 2015
6th annual clinical trials summit 2015
 
Presentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and researchPresentation for spbt 2013 meeting background and research
Presentation for spbt 2013 meeting background and research
 
Dina-CV
Dina-CVDina-CV
Dina-CV
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Pharmacy Orientation.pdf
Pharmacy Orientation.pdfPharmacy Orientation.pdf
Pharmacy Orientation.pdf
 

More from Pharmaceutical & Medical Professionals

Trends in Medical Affairs
Trends in Medical AffairsTrends in Medical Affairs
Trends in Medical Affairs
Pharmaceutical & Medical Professionals
 
How to best used LinkedIn
How to best used LinkedInHow to best used LinkedIn
How to best used LinkedIn
Pharmaceutical & Medical Professionals
 
Tips for Managerial Success
Tips for Managerial Success  Tips for Managerial Success
Tips for Managerial Success
Pharmaceutical & Medical Professionals
 
Tips for Managerial Success
Tips for Managerial SuccessTips for Managerial Success
Tips for Managerial Success
Pharmaceutical & Medical Professionals
 
Personal Branding - the key success factor for promotions and new opportunities
Personal Branding - the key success factor for promotions and new opportunitiesPersonal Branding - the key success factor for promotions and new opportunities
Personal Branding - the key success factor for promotions and new opportunities
Pharmaceutical & Medical Professionals
 
Industry Trends in Innovation
Industry Trends in InnovationIndustry Trends in Innovation
Industry Trends in Innovation
Pharmaceutical & Medical Professionals
 
Redundancy - building for the future with today's available talent
Redundancy - building for the future with today's available talentRedundancy - building for the future with today's available talent
Redundancy - building for the future with today's available talent
Pharmaceutical & Medical Professionals
 
EI - An Overview
EI - An OverviewEI - An Overview
EI Competencies
EI CompetenciesEI Competencies
Employee turnover and maximizing staff retention
Employee turnover and maximizing staff retentionEmployee turnover and maximizing staff retention
Employee turnover and maximizing staff retention
Pharmaceutical & Medical Professionals
 

More from Pharmaceutical & Medical Professionals (10)

Trends in Medical Affairs
Trends in Medical AffairsTrends in Medical Affairs
Trends in Medical Affairs
 
How to best used LinkedIn
How to best used LinkedInHow to best used LinkedIn
How to best used LinkedIn
 
Tips for Managerial Success
Tips for Managerial Success  Tips for Managerial Success
Tips for Managerial Success
 
Tips for Managerial Success
Tips for Managerial SuccessTips for Managerial Success
Tips for Managerial Success
 
Personal Branding - the key success factor for promotions and new opportunities
Personal Branding - the key success factor for promotions and new opportunitiesPersonal Branding - the key success factor for promotions and new opportunities
Personal Branding - the key success factor for promotions and new opportunities
 
Industry Trends in Innovation
Industry Trends in InnovationIndustry Trends in Innovation
Industry Trends in Innovation
 
Redundancy - building for the future with today's available talent
Redundancy - building for the future with today's available talentRedundancy - building for the future with today's available talent
Redundancy - building for the future with today's available talent
 
EI - An Overview
EI - An OverviewEI - An Overview
EI - An Overview
 
EI Competencies
EI CompetenciesEI Competencies
EI Competencies
 
Employee turnover and maximizing staff retention
Employee turnover and maximizing staff retentionEmployee turnover and maximizing staff retention
Employee turnover and maximizing staff retention
 

Recently uploaded

BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
Nguyen Thanh Tu Collection
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Denish Jangid
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
Celine George
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Himanshu Rai
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
heathfieldcps1
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
WaniBasim
 
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Diana Rendina
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
eBook.com.bd (প্রয়োজনীয় বাংলা বই)
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
adhitya5119
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
Katrina Pritchard
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptxPrésentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
siemaillard
 

Recently uploaded (20)

BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 InventoryHow to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
 
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptxPrésentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
 

A Day in the Life of a Medical Director

  • 1. A Day in the Life of a Medical Director Dr Glenn Carter Healthcare Professionals Group
  • 2. Medical Director’s role The role of a Medical Director is to oversee all activities within a company's Medical Department and to contribute to company-wide business operations through involvement in the senior leadership team.
  • 3. Medical Director’s activities 1. Emails 2. Phone Calls 3. Internal Meetings 4. External Meetings 5. Travel
  • 4. Emails Head Office questions requesting updates on clinical trials, regulatory or health economics submissions eg “How is patient recruitment going in x trial”? “What did x investigator think about the draft protocol for the new trial”? “How many patients will Australia be able to commit to the global clinical trial program for x compound? “Here are the results from x trial to discuss with your investigators” “Here are the responses to the questions the TGA are asking about the compound which is being reviewed for registration” “Here is some additional data to include in the reimbursement submission” “Here is a report on the serious adverse events in x trial”
  • 5. Phone Calls Calls will be received from trial investigators about Inclusion/ Exclusion criteria, or the clinical protocol: "My patient is also taking x drug can I enrol him"; "If the patient had missed 2 visits can they continue in the trial?” Calls will also be coming in from CRAs who are on-site at hospitals doing monitoring visits "The study nurse needs more drug and I need your help in getting head office to send it quickly"
  • 6. Phone Calls There will also be phone calls from:  the press asking for a response to an overseas news piece  patient associations regarding sponsorship  doctors requesting patient-specific medical advice  investigators asking to have their own trials supported As the medical leader within companies the Medical Director is frequently asked to publicly comment on a range of topics, and would have undergone media training.
  • 7. Internal Meetings In the Clinical Research meetings a whole range of issues will be discussed. Progress made in all the clinical trials will be regularly reviewed. Topics of conversation will centre around:  Ethics Committee approvals  strategies to increase patient recruitment  availability of trial materials  site issues and management  trial budgets and payments  adverse event reporting New trial protocols will also be discussed. This will involve reviewing protocols sent from Head Office, discussing whether they are applicable to Australian medical practice and identifying potential investigators.
  • 8. Internal Meetings In the Regulatory meetings the topics will include:  registration of New Chemical Entities, new dosage forms and new indications  updates on timelines for regulatory submissions  discussion on bottlenecks and issues which may delay registration.  correspondence from the TGA will be reviewed and appropriate responses drafted  the wording of PIs and CMIs will be finalised During the Medical Information meetings company promotional literature will be analysed to ensure that it meets Code of Conduct guidelines, with approval being given by the Medical Director prior to printing and distribution.
  • 9. Internal Meetings The focus during the Health Economics meetings is on reimbursement and market access:  the strategy for PBAC submissions will be decided upon  the clinical data supporting the pricing strategy will be analysed  additional supporting trials or analyses will be considered  input from consultants (eg on economic modelling) and direction from head office (eg on international pricing) will be used to determine the negotiation strategy with the PBAC  discussion on the design of future clinical trials to ensure that they collect the right information for submissions The Medical Director's input will also include suggesting disease relevant health status questionnaires and Quality of Life instruments to incorporate into the trial design, as well as suitable gold standard comparator treatments relevant to medical practice in Australia.
  • 10. Internal Meetings The Medical Director is also involved with across-company meetings. The Medical Director's medical knowledge and understanding of how patients are treated is useful when annual marketing plans are devised. Topics during these meetings include:  sales forecasts  market trends  competitor activity  promotional programs  disease management programs  patient characteristics  prescriber behaviour
  • 11. Internal Meetings During senior management meetings (also attended by the Managing Director, Sales and Marketing Director, Operations Director, Human Resources Director and Finance Director) the Medical Director will contribute to across- business discussions where a wide range of topics will include:  operational and strategic planning  resource management  learning and development plans  succession planning  manufacturing and supply chain issues  policy development  external and corporate affairs initiatives  crisis management  monitoring of the company's trading and cash flow position
  • 12. External Meetings The Medical Director may be responsible for assembling and managing Key Opinion Leader advisory groups for key products. The advisory group's role is to:  review particular products (pre-launch or marketed)  discuss where the product fits into the management of the patient's disease  to suggest synergies with other company products  to discuss leading developments in the field Information gained during these discussions is then summarized and made available to marketing and R&D functions.
  • 13. External Meetings It is also likely that the Medical Director will participate in Medicines Australia and other industry committees thus ensuring that their company has a high level of professional standing. External meetings will also include co-visiting doctors with CRAs to discuss current and future clinical trials, and with sales reps to discuss the company's marketed products.
  • 14. Travel Canberra to meet with the TGA to discuss scientific and clinical data with the regulators and build on-going relationships with key people. Overseas meetings with Medical Directors from other countries there will be discussions on global clinical development programs; regulatory timelines for key compounds and strategies to gather data in support of reimbursement and market access. Regional offices (eg Singapore) or global Head Office (US, UK or Europe) for meetings with internal colleagues to build relationships; to request resources and headcount for Australia and to provide updates on clinical trials and regulatory, reimbursement and other medical issues
  • 15. Summary The typical day of a Medical Director within an Australian pharmaceutical company is varied and complex. As the company's senior medical person they are called upon to use their clinical knowledge and understanding of patient treatment protocols to advise their internal colleagues on clinical research, regulatory, medical information, reimbursement and sales and marketing issues. As a member of the senior leadership team they use their medical knowledge and commercial acumen to contribute to the overall success of the company.
  • 16. Health & Aged Care Professionals Recruiting all clinical care, management and operational positions with Public and Private Hospitals; Medical Practices; Imaging Service Providers; Health Insurance Funds; and Aged Care providers, residential facilities and affiliated service providers www.hacpconnect.com Pharmaceutical & Medical Professionals Recruiting all positions, at all levels, into biotechnology, medical devices, pharmaceutical and scientific companies www.pmpconnect.com Rural & Remote Healthcare Professionals Recruiting doctors, nurses, allied health professionals, and healthcare administrators into rural and remote hospitals and medical practices www.rrhpconnect.com